GFAP and amyotrophic lateral sclerosis: Treatment significantly decreased the fluorescence intensity of IBA1 and GFAP staining by 10–20% in mice treated with AUT00201 compared to mice treated with vehicle, indicating that AUT00201 reduces microglia activation and gliosis in this murine model of ALS.